PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3

Seung Hoi Koo, Hiroaki Satoh, Stephan Herzig, Chih Hao Lee, Susan Hedrick, Rohit Kulkarni, Ronald M. Evans, Jerrold Olefsky, Marc Montminy

Research output: Contribution to journalArticlepeer-review

483 Citations (Scopus)


Insulin resistance is a major hallmark in the development of type 2 diabetes, which is characterized by an impaired ability of insulin to inhibit glucose output from the liver and to promote glucose uptake in muscle. The nuclear hormone receptor coactivator PGC-1 (peroxisome proliferator-activated (PPAR)-γ coactivator-1) has been implicated in the onset of type 2 diabetes. Hepatic PGC-1 expression is elevated in mouse models of this disease, where it promotes constitutive activation of gluconeogenesis and fatty acid oxidation through its association with the nuclear hormone receptors HNF-4 and PPAR-α, respectively. Here we show that PGC-1-deficient mice, generated by adenoviral delivery of PGC-1 RNA interference (RNAi) to the liver, experience fasting hypoglycemia. Hepatic insulin sensitivity was enhanced in PGC-1-deficient mice, reflecting in part the reduced expression of the mammalian tribbles homolog TRB-3, a fasting-inducible inhibitor of the serine-threonine kinase Akt/PKB (ref. 6). We show here that, in the liver, TRB-3 is a target for PPAR-α. Knockdown of hepatic TRB-3 expression improved glucose tolerance, whereas hepatic overexpression of TRB-3 reversed the insulin-sensitive phenotype of PGC-1-deficient mice. These results indicate a link between nuclear hormone receptor and insulin signaling pathways, and suggest a potential role for TRB-3 inhibitors in the treatment of type 2 diabetes.

Original languageEnglish
Pages (from-to)530-534
Number of pages5
JournalNature Medicine
Issue number5
Publication statusPublished - 2004 May
Externally publishedYes

Bibliographical note

Funding Information:
We thank K. Suter and L. Vera for performing injections, and C.R. Kahn (Joslin Diabetes Center) for LIRKO mice. This work was supported by National Institutes of Health grant GM RO1 37828 (M.M.), the American Diabetes Association, the Hillblom Foundation and Deutsche Forschungsgemeinschaft grant He3260/1-1 (S.H.).

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)


Dive into the research topics of 'PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3'. Together they form a unique fingerprint.

Cite this